Poseida Therapeutics (PSTX) Insider Trading & Ownership → This is the best new way to score with AI (From Weiss Ratings) (Ad) Free PSTX Stock Alerts $3.35 -0.11 (-3.18%) (As of 01:04 PM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Poseida Therapeutics (NASDAQ:PSTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.10%Number OfInsiders Buying(Last 3 Years)3Amount OfInsider Buying(Last 3 Years)$9.26 MNumber OfInsiders Selling(Last 3 Years)2Amount OfInsider Selling(Last 3 Years)$1.82 M Get PSTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Poseida Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address PSTX Insider Buying and Selling by Quarter Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… Poseida Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/8/2022Eric OstertagChairmanBuy142,857$3.50$499,999.50 8/8/2022Life Sciences Holdings L MalinMajor ShareholderBuy2,150,000$3.50$7,525,000.00 8/3/2022Eric OstertagChairmanSell160,696$3.69$592,968.24 3/16/2022Kerry D IngallsCOOBuy3,000$3.98$11,940.00 12/6/2021Life Sciences Holdings L MalinDirectorBuy1,828$6.90$12,613.20 12/1/2021Life Sciences Holdings L MalinDirectorBuy18,365$6.85$125,800.25 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 11/29/2021Life Sciences Holdings L MalinDirectorBuy11,057$6.89$76,182.73 11/26/2021Life Sciences Holdings L MalinDirectorBuy27,251$6.81$185,579.31 11/23/2021Life Sciences Holdings L MalinDirectorBuy14,625$6.77$99,011.25 11/18/2021Life Sciences Holdings L MalinDirectorBuy71,312$7.18$512,020.16 11/17/2021Kerry D IngallsCOOBuy2,000$7.00$14,000.00 11/16/2021Life Sciences Holdings L MalinDirectorBuy27,680$7.17$198,465.60 11/8/2021Eric OstertagCEOSell18,924$7.09$134,171.16 10/1/2021Eric OstertagCEOSell20,029$7.02$140,603.58 9/20/2021Eric OstertagCEOSell20,000$8.00$160,000.00 9/14/2021Eric OstertagCEOSell20,000$8.14$162,800.00 8/20/2021Matthew A SpearInsiderSell4,000$8.79$35,160.00 7/1/2021Eric OstertagCEOSell20,563$9.77$200,900.51 6/11/2021Matthew A SpearInsiderSell4,000$9.44$37,760.00 6/1/2021Eric OstertagCEOSell41,194$8.61$354,680.34 (Data available from 1/1/2013 forward) PSTX Insider Trading Activity - Frequently Asked Questions Who is on Poseida Therapeutics's Insider Roster? The list of insiders at Poseida Therapeutics includes Eric Ostertag, Kerry D Ingalls, Life Sciences Holdings L Malin, and Matthew A Spear. Learn more on insiders at PSTX. What percentage of Poseida Therapeutics stock is owned by insiders? 2.10% of Poseida Therapeutics stock is owned by insiders. Learn more on PSTX's insider holdings. Which Poseida Therapeutics insiders have been buying company stock? The following insiders have purchased PSTX shares in the last 24 months: Eric Ostertag ($499,999.50), and Life Sciences Holdings L Malin ($7,525,000.00). How much insider buying is happening at Poseida Therapeutics? Insiders have purchased a total of 2,292,857 PSTX shares in the last 24 months for a total of $8,024,999.50 bought. Which Poseida Therapeutics insiders have been selling company stock? The following insider sold PSTX shares in the last 24 months: Eric Ostertag ($592,968.24). How much insider selling is happening at Poseida Therapeutics? Insiders have sold a total of 160,696 Poseida Therapeutics shares in the last 24 months for a total of $592,968.24 sold. More Insider Trading Tools from MarketBeat Related Companies: CADL Insider Buying ADAP Insider Buying IVVD Insider Buying STRO Insider Buying FENC Insider Buying CHRS Insider Buying AVXL Insider Buying AGEN Insider Buying MGX Insider Buying CMPX Insider Buying Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 4 Small-Cap Energy Stocks Insiders are Buying 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are Buying This page (NASDAQ:PSTX) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden to Drop BOMBSHELL June 13th?Paradigm PressRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldElon to Transform U.S. Economy? Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityThe most important AI company you've never heard ofManward PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyWATCH: The Truth About InflationBirch Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Poseida Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.